1175526-32-5

Basic information

• Product Name: 2-BROMO-N-ETHYL-5-(TRIFLUOROMETHYL)-BENZENEMETHANAMINE
• Synonyms: 2-BROMO-N-ETHYL-5-(TRIFLUOROMETHYL)-BENZENEMETHANAMINE
• CAS NO: 1175526-32-5
• Molecular Formula: C₁₀H₁₁BrF₃N
• Molecular Weight: 282.1002496
• Mol File: 1175526-32-5.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-BROMO-N-ETHYL-5-(TRIFLUOROMETHYL)-BENZENEMETHANAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-N-ETHYL-5-(TRIFLUOROMETHYL)-BENZENEMETHANAMINE(1175526-32-5)
• EPA Substance Registry System: 2-BROMO-N-ETHYL-5-(TRIFLUOROMETHYL)-BENZENEMETHANAMINE(1175526-32-5)

Safety Data

• Hazardous Substances Data: 1175526-32-5(Hazardous Substances Data)

Upstream product

• 75-04-7 ethylamine 
• 102684-91-3 2-bromo-5-(trifluoromethyl)benzaldehyde 

Downstream Products

• 1420071-09-5 {3-[2-{[(cyclopropylcarbonyl)(ethyl)amino]methyl}-4-(trifluoromethyl)phenyl]-1H-pyrrolo[3,2-c]pyridin-1-yl}acetic acid 
• 1420071-00-6 {3-[2-{[(cyclopropylcarbonyl)(ethyl)amino]methyl}-4-(trifluoromethyl)phenyl]-1H-pyrrolo[3,2-b]pyridin-1-yl}acetic acid 
• 1219936-59-0 N’-benzyl-N-[2-bromo-5-(trifluoromethyl)benzyl]-N-ethylurea 
• 1420069-08-4 ethyl {1-[2-{[(cyclopropylcarbonyl)(ethyl)amino]methyl}-4-(trifluoromethyl)phenyl]-1H-indol-3-yl}acetate 
• 1420069-98-2 {3-[2-{[(cyclopropylcarbonyl)(ethyl)amino]methyl}-4-(trifluoromethyl)phenyl]-1H-indol-1-yl}acetic acid 
• 1420068-49-0 N-[2-[(Z)-2-ethoxyvinyl]-5-(trifluoromethyl)benzyl]-N-ethylcyclopropanecarboxamide 
• 1420069-21-1 N-[2-(5-cyano-1H-indol-3-yl)-5-(trifluoromethyl)benzyl]-N-ethylcyclopropanecarboxamide 
• 1420069-14-2 N-ethyl-N-[2-(1H-indol-3-yl)-5-(trifluoromethyl)benzyl]cyclopropanecarboxamide 
• 1420069-12-0 ethyl {3-[2-{[(cyclopropylcarbonyl)(ethyl)amino]methyl}-4-(trifluoromethyl)phenyl]-1H-indol-1-yl}acetate 
• 1219936-26-1 N-ethyl-N-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)benzyl]cyclopropanecarboxamide 
• 1420071-02-8 {3-[2-{[(cyclopropylcarbonyl)(ethyl)amino]methyl}-4-(trifluoromethyl)phenyl]-5-methyl-1H-pyrrolo[3,2-b]pyridin-1-yl}acetic acid 
• 1420071-23-3 {3-[2-{[(cyclopropylcarbonyl)(ethyl)amino]methyl}-4-(trifluoromethyl)phenyl]imidazo[1,5-a]pyridin-1-yl}acetic acid 
• 1420532-41-7 ?N-ethyl-N-[2-(2-methylpyrrolo[1,2-b]pyridazin-7-yl)-5-(trifluoromethyl)benzyl]cyclopropanecarboxamide 
• 1420532-40-6 tert-butyl {2-[2-{[(cyclopropylcarbonyl)(ethyl)amino]methyl}-4-(trifluoromethyl)phenyl]-5-[(1E)-3-oxobut-1-en-1-yl]-1H-pyrrol-1-yl}carbamate 

Relevant articles and documents

NEW CRTH2 ANTAGONISTS

The present invention relates to compounds of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by CRTh2 antagonist activity.

New CRTh2 antagonists

The present invention relates to compounds of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by CRTh2 antagonist activity.

HETEROARYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS

Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such antagonists of PGD2 receptors, alone or in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.